公司新闻(英文)
April 19, 2018 / 12:05 PM / 7 months ago

BRIEF-Athenex Receives U.S. FDA Orphan Drug Designation For Oraxol For The Treatment Of Angiosarcoma

1 分钟阅读

April 19 (Reuters) - Athenex Inc:

* ATHENEX, INC. RECEIVES U.S. FDA ORPHAN DRUG DESIGNATION FOR ORAXOL FOR THE TREATMENT OF ANGIOSARCOMA

* ATHENEX INC - WILL BE INITIATING ANGIOSARCOMA CLINICAL STUDY SOON Source text for Eikon: Further company coverage:

我们的标准：汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below